Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Astra boosts emerging markets with Aurobindo deal
Reuters
Tuesday, September 7, 2010 - 12:41pm
tags:
emerging markets, India, AstraZeneca, Aurobindo
J&J Wants Remicade Damages From Merck
Pharmalot
Tuesday, September 7, 2010 - 12:39pm
tags:
Remicade, Merck, JNJ
Biovail-Valeant combo will cost 25% of all jobs
Fierce Biotech
Tuesday, September 7, 2010 - 12:38pm
tags:
Biovail, Valeant Pharmaceuticals, layoffs, M&A
Roche Layoffs: Whose Jobs Are Safe, and Whose Aren’t?
BNET Pharma
Tuesday, September 7, 2010 - 12:12pm
tags:
Roche, Genentech, layoffs
Idenix shares crushed; drug sector indexes slide
Marketwatch
Tuesday, September 7, 2010 - 12:11pm
tags:
Idenix, drug stocks
Big Pharma Headed for More Deals, Less New Drug Applications
Seeking Alpha
Tuesday, September 7, 2010 - 12:09pm
tags:
Big Pharma, M&A, Pfizer, Merck, Novartis, GSK, Genzyme, Celgene, AstraZeneca, Abbott Laboratories, FoldRx
Sanofi hints at higher Genzyme bid as GSK remains on the sidelines
Fierce Biotech
Tuesday, September 7, 2010 - 12:04pm
tags:
GSK, M&A, Sanofi, Genzyme
Glaxo slides on Avandia woes in U.K.
Marketwatch
Tuesday, September 7, 2010 - 12:03pm
tags:
GSK, Avandia, diabetes, UK
Somaxon Pharmaceuticals Announces Commercial Availability of Silenor
Yahoo
Tuesday, September 7, 2010 - 9:56am
tags:
Silenor, Somaxon, insomnia, P&G
GSK R&D head says no plan to bid for Genzyme-paper
Reuters
Tuesday, September 7, 2010 - 9:45am
tags:
GSK, Genzyme, M&A, Sanofi
Taiko Pharmaceutical Gains Most Since Listing on Drug-Resistant Bacteria
Bloomberg
Tuesday, September 7, 2010 - 9:44am
tags:
Taiko, antibiotics, antiseptics, Japan
Elan’s board spat hits Dublin High Court
FT.com
Tuesday, September 7, 2010 - 9:42am
tags:
Elan
CellDex Therapeutics Gets Hammered After Divorce With Pfizer, Time to Buy?
Seeking Alpha
Tuesday, September 7, 2010 - 9:41am
tags:
Pfizer, Celldex
What went wrong with Gardasil
CNN/Fortune
Tuesday, September 7, 2010 - 9:40am
tags:
Merck, vaccines, Gardasil, HPV, cervical cancer
Pressure on GSK as calls for Avandia withdrawal gather pace
Pharma Times, UK
Monday, September 6, 2010 - 10:17am
tags:
GSK, Avandia, diabetes
Aurobindo Signs Agreement to Supply Antibiotic, Heart Drugs to AstraZeneca
Bloomberg
Monday, September 6, 2010 - 10:13am
tags:
Aurobindo, AstraZeneca, antibiotics
Glaxo's Avandia Should Be Pulled From U.K. Market, BMJ Chief Editor Says
Bloomberg
Monday, September 6, 2010 - 10:11am
tags:
GSK, Avandia, diabetes, Bristol-Myers Squibb
Axial Capital Can't Get Enough of QLT
Seeking Alpha
Monday, September 6, 2010 - 10:09am
tags:
QLT
Does Bristol-Meyers Squibb Pass Buffett's Test?
Motley Fool
Monday, September 6, 2010 - 10:07am
tags:
Warren Buffett, Bristol-Myers Squibb
Arena's Lorcaserin: Weighed Down by Qnexa and Meridia
Seeking Alpha
Monday, September 6, 2010 - 10:04am
tags:
Arena Pharmaceuticals, obesity, lorcaserin, Qnexa, Meridia, Vivus

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.